Communiqués ANALYTICA

Actions

Marché Fermé - Australian S.E. Autres places de cotation 05:32:57 28/02/2023			Varia. 5j.	Varia. 1 janv.
0,001 ^AUD	-.--%		-.--%	-.--%

2023	Le Dr Michael Monsour assumera la fonction de président exécutif d'Analytica Limited	CI
2023	Analytica Limited annonce la démission de Geoff Daly en tant que CEO	CI

Analytica : Appendix4d and half year audit reviewed financial report	23/02/22	PU
Analytica : CEO presentation to AGM	25/11/21	PU
Analytica : Announces Expansion of Enhanced Infusion System into Middle East	27/04/21	AQ
Analytica Announces Expansion of PeriCoach® Pelvic Health Solution into China	31/03/21	GL
Presswire: UK firm Global Analytica refutes a claim of copyright infringement	12/12/19	AQ
Analytica : Results of Annual General Meeting	22/11/18	PU
Analytica : Appendix 4C	31/10/18	PU
Analytica : PeriCoach Manufacturing Update	08/10/18	PU
Analytica : Change in Registered Office	03/09/18	PU
Analytica : Appendix 3Y	30/08/18	PU
Analytica : PeriCoach® Real-World Data Analysis Reveals Statistically Significant Reduction in Incontinence Symptoms Within 3 Weeks	21/08/18	PU
Analytica : USFDA Issues Warning Letters to Vaginal Rejuvenation Laser Manufacturers for Deceptive Treatment Claims	01/08/18	PU
Analytica : raises $1,532m from Options and Placements	12/06/18	PU
Analytica : PeriCoach Expands Clinical Indication to Include Pelvic Organ Prolapse	02/05/18	PU
Analytica : Notice of Option Expiry	27/12/17	PU
Analytica : Appointment of Navigant Capital Advisors	06/11/17	PU
Analytica : Appendix 4C	31/10/17	PU
Analytica : Entitlement Offer Shortfall Share Issue	31/10/17	PU
Analytica : Corporate Plan Progress Update	27/09/17	PU
Analytica : Replacement Prospectus	26/09/17	PU

Aucun résultat pour cette recherche